Inventor · disambiguated record
Thomas Schlake
Also filed as: SCHLAKE THOMAS
32 granted patents·18 pending applications·901 citations·filing 2002–2025
98Inventor score
Top patents by PatentIndex Score
50 records- 0198US11345920B2Artificial nucleic acid molecules for improved protein expressionCUREVAC AG·Filed 2021·Granted May 31, 2022·17 cites·28 claims
- 0298US11286492B2Artificial nucleic acid molecules for improved protein expressionCUREVAC AG·Filed 2021·Granted Mar 29, 2022·22 cites·30 claims
- 0398US11110156B2Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigenCUREVAC AG·Filed 2018·Granted Sep 7, 2021·28 cites·18 claims
- 0498US10912826B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigenCUREVAC AG·Filed 2020·Granted Feb 9, 2021·45 cites·21 claims
- 0598US10898589B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic proteinCUREVAC AG·Filed 2018·Granted Jan 26, 2021·28 cites·16 claims
- 0698US10898584B2Modified RNA with decreased immunostimulatory propertiesCUREVAC AG·Filed 2016·Granted Jan 26, 2021·30 cites·17 claims
- 0798US10799577B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigenCUREVAC AG·Filed 2018·Granted Oct 13, 2020·28 cites·22 claims
- 0898US10751424B2Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acidsCUREVAC AG·Filed 2018·Granted Aug 25, 2020·29 cites·17 claims
- 0998US10682406B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigenCUREVAC AG·Filed 2018·Granted Jun 16, 2020·29 cites·22 claims
- 1098US10166283B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigenCUREVAC AG·Filed 2017·Granted Jan 1, 2019·37 cites·19 claims
- 1198US10111968B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic proteinCUREVAC AG·Filed 2016·Granted Oct 30, 2018·39 cites·20 claims
- 1298US9839697B2Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded proteinCUREVAC AG·Filed 2015·Granted Dec 12, 2017·39 cites·20 claims
- 1398US9669089B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigenCUREVAC GMBH·Filed 2013·Granted Jun 6, 2017·107 cites·21 claims
- 1498US9447431B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic proteinCUREVAC GMBH·Filed 2013·Granted Sep 20, 2016·70 cites·16 claims
- 1597US11761009B2Artificial nucleic acid molecules for improved protein expressionCureVac SE·Filed 2022·Granted Sep 19, 2023·5 cites·60 claims
- 1697US11149278B2Artificial nucleic acid molecules for improved protein expressionCUREVAC AG·Filed 2015·Granted Oct 19, 2021·31 cites·20 claims
- 1797US10653799B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded proteinCUREVAC AG·Filed 2017·Granted May 19, 2020·28 cites·20 claims
- 1897US10610605B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic proteinCUREVAC AG·Filed 2018·Granted Apr 7, 2020·28 cites·17 claims
- 1997US10232024B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigenCUREVAC AG·Filed 2013·Granted Mar 19, 2019·32 cites·15 claims
- 2097US9907862B2Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acidsCUREVAC AG·Filed 2016·Granted Mar 6, 2018·35 cites·25 claims
- 2197US8703906B2Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acidsBAUMHOF PATRICK·Filed 2010·Granted Apr 22, 2014·68 cites·17 claims
- 2296US10010592B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigenCUREVAC AG·Filed 2013·Granted Jul 3, 2018·36 cites·15 claims
- 2396US9314535B2Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acidsCUREVAC GMBH·Filed 2014·Granted Apr 19, 2016·32 cites·15 claims
- 2495US12442005B2Artificial nucleic acid molecules for improved protein expressionCureVac SE·Filed 2023·Granted Oct 14, 2025·1 cites·41 claims
- 2595US9234013B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded proteinTHESS ANDREAS·Filed 2011·Granted Jan 12, 2016·44 cites·19 claims
- 2692US2025352636A1Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigenCureVac SE·Filed 2024·Application pending·0 cites
- 2790US11697816B2Artificial nucleic acid moleculesCureVac SE·Filed 2016·Granted Jul 11, 2023·5 cites·22 claims
- 2889US11739335B2Nucleic acids encoding CRISPR-associated proteins and uses thereofCureVac SE·Filed 2018·Granted Aug 29, 2023·7 cites·18 claims
- 2987US2025152745A1Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded proteinCureVac SE·Filed 2024·Application pending·0 cites
- 3086US12109275B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded proteinCureVac SE·Filed 2020·Granted Oct 8, 2024·1 cites·19 claims
- 3179US12371699B2Nucleic acids encoding CRISPR-associated proteins and uses thereofCureVac SE·Filed 2023·Granted Jul 29, 2025·0 cites·16 claims
- 3279US2024294928A1Artificial nucleic acid moleculesCureVac SE·Filed 2024·Application pending·0 cites
- 3378US12201680B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigenCureVac SE·Filed 2020·Granted Jan 21, 2025·0 cites·23 claims
- 3478US2024101608A1Optimized nucleic acid moleculesCureVac SE·Filed 2023·Application pending·0 cites
- 3575US2025304976A1Nucleic acids encoding crispr-associated proteins and uses thereofCureVac SE·Filed 2025·Application pending·0 cites
- 3674US2021060181A1Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic proteinCUREVAC AG·Filed 2020·Application pending·0 cites
- 3772US2020338215A1Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acidsCUREVAC AG·Filed 2020·Application pending·0 cites
- 3872US2023399649A1Artificial nucleic acid moleculesCureVac SE·Filed 2023·Application pending·0 cites
- 3970US2021393755A1Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigenCUREVAC AG·Filed 2021·Application pending·0 cites
- 4069US2011053829A1Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acidsCUREVAC GMBH·Filed 2009·Application pending·0 cites
- 4164US2020399322A1Optimized nucleic acid moleculesCUREVAC AG·Filed 2020·Application pending·0 cites
- 4263US2025171789A1Artificial nucleic acid moleculesCureVac SE·Filed 2025·Application pending·0 cites
- 4362US2019255161A1Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigenCUREVAC AG·Filed 2019·Application pending·0 cites
- 4460US12258567B2Artificial nucleic acid moleculesCureVac SE·Filed 2016·Granted Mar 25, 2025·0 cites·18 claims
- 4558US2019345504A1Artificial nucleic acid moleculesCUREVAC AG·Filed 2019·Application pending·0 cites
- 4655US2018312545A1Optimized nucleic acid moleculesCUREVAC AG·Filed 2016·Application pending·0 cites
- 4752US2022296628A1Rna combinations and compositions with decreased immunostimulatory propertiesCUREVAC AG·Filed 2020·Application pending·0 cites
- 4849US7468246B2Identification and use of inhibitors of hair growthMAX PLANCK GESELLSCHAFT·Filed 2002·Granted Dec 23, 2008·0 cites·12 claims
- 4948US2018148727A1Artificial nucleic acid moleculesCUREVAC AG·Filed 2015·Application pending·0 cites
- 5041US2022233568A1Novel artificial nucleic acid moleculesCUREVAC AG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Schlake files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →